neurology
Peripheral Neuropathy Assessment
Systematic evaluation of peripheral neuropathy — pattern recognition, investigation, and common causes
Source: EFNS / BSN guidelines
Step 1 of ~6
info
Peripheral Neuropathy
Characterise: sensory, motor, or mixed. Distribution: length-dependent (glove-and-stocking), mononeuropathy, or multifocal. Onset: acute, subacute, chronic.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Oxycodone with naloxone · Strong opioid + peripheral opioid antagonist
- Bendroflumethiazide · Thiazide Diuretic
- Loperamide · Opioid Receptor Agonist (Peripheral — Antidiarrhoeal)
- Domperidone · Prokinetic Antiemetic (Peripheral Dopamine Antagonist)
- Loperamide Hydrochloride · Antidiarrhoeal (Opioid Receptor Agonist — Peripheral)
- Methylnaltrexone bromide · Peripheral μ-opioid receptor antagonist
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS
Decision support only. Always apply local guidelines and clinical judgement.